These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 784944

  • 1. [Synthesis of optically active 5- (3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride and their beta-adrenergic blocking activities (author's transl)].
    Yamamoto K, Uno T, Ishihara T, Nakagawa K.
    Yakugaku Zasshi; 1976 Mar; 96(3):289-92. PubMed ID: 784944
    [No Abstract] [Full Text] [Related]

  • 2. [Metabolic fate of carteolol hydrochloride [5-(3-tert-butylamino-2-hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride, OPC-1085], a new beta-blocker. V. Identification of metabolites in rat, dog and human (author's transl)].
    Mori H, Kido M, Murakami N, Morita S, Kohri H.
    Yakugaku Zasshi; 1977 Apr; 97(4):305-8. PubMed ID: 327055
    [No Abstract] [Full Text] [Related]

  • 3. [Fluorometric determination of 5-(3-tert-butylamino-2hydroxypropoxy)-3,4-dihydrocarbostyril hydrochloride (OPC-1085) and structure of fluorescent substance (author's transl)].
    Kido M, Mori H, Masuda S, Kohri H, Nakagawa K.
    Yakugaku Zasshi; 1977 Jan; 97(1):1-4. PubMed ID: 320307
    [No Abstract] [Full Text] [Related]

  • 4. [Synthesis of 5-(3-tert-butylamino-2-hydroxypropoxy)-8-hydroxy-3,4-dihydrocarbostyril hydrochloride and its beta-adrenergic blocking activity].
    Uchida M, Tominaga M, Oka K, Tone H, Uno T.
    Yakugaku Zasshi; 1976 May; 96(5):571-7. PubMed ID: 9501
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Adrenergic beta-receptor blocking activity of (3-amino-2-hydroxy)propoxy-3, 4-dihydrocarbostyril derivatives in anesthetized dog (author's transl)].
    Nakagawa K, Murakami N, Yoshizaki S, Tominaga M, Mori H.
    Yakugaku Zasshi; 1974 May; 94(5):613-6. PubMed ID: 4153735
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Syntheses and beta-adrenergic blocking activities of the optical isomers of 8-acetonyloxyl-5-[3-(3,4-dimethoxyphenethylamino)-2-hydroxypropoxy]-3,4-dihydrocarbostyril.
    Yo E, Nakagawa K, Hoshino Y.
    Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2157-60. PubMed ID: 6119164
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vasodilatory mechanism of levobunolol on vascular smooth muscle cells.
    Dong Y, Ishikawa H, Wu Y, Yoshitomi T.
    Exp Eye Res; 2007 Jun; 84(6):1039-46. PubMed ID: 17459374
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
    Gloger K.
    Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
    [Abstract] [Full Text] [Related]

  • 17. Comparison of a noncardioselective beta-adrenoceptor blocker and a cardioselective blocker in reducing aqueous flow in humans.
    Gaul GR, Will NJ, Brubaker RF.
    Arch Ophthalmol; 1989 Sep; 107(9):1308-11. PubMed ID: 2571327
    [Abstract] [Full Text] [Related]

  • 18. Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
    Baldwin JJ, Engelhardt EL, Hirschmann R, Ponticello GS, Atkinson JG, Wasson BK, Sweet CS, Scriabine A.
    J Med Chem; 1980 Jan; 23(1):65-70. PubMed ID: 6102151
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological profile of a new beta-adrenoceptor blocker, 4-[3-(tert-butylamino)-2-hydroxypropoxy]-N-methylisocarbostyril hydrochloride (N-696).
    Nakagawa Y, Sugai T, Chin WP, Shibuya T, Hashimoto K, Imai S.
    Arzneimittelforschung; 1984 Jan; 34(2):194-9. PubMed ID: 6144313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.